https://old.international-biopharma.com/amgen-completes-28b-horizon-buyout-that-was-challenged-by-ftc/ 2023-10-09T08:37:13+00:00 https://old.international-biopharma.com/orchard-sells-to-kyowa-kirin-in-gene-therapy-buyout/ 2023-10-09T08:36:18+00:00 https://old.international-biopharma.com/abbvie-acquires-parkinsons-drug-in-latest-biotech-buyout/ 2023-10-09T08:34:28+00:00 https://old.international-biopharma.com/drug-discovery-2023/ 2023-10-05T13:26:47+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/10/ELRIG-DD23-reg_instagram-2.jpg https://old.international-biopharma.com/structure-boosted-by-early-data-for-experimental-obesity-drug/ 2023-10-02T08:27:56+00:00 https://old.international-biopharma.com/intercept-after-biotech-rollercoaster-ride-agrees-to-buyout-by-alfasigma/ 2023-10-02T08:26:53+00:00 https://old.international-biopharma.com/new-rsv-vaccines-can-be-powerful-tools-but-rollout-poses-test/ 2023-10-02T08:25:15+00:00 https://old.international-biopharma.com/brainstorms-als-therapy-not-effective-fda-panel-finds/ 2023-10-02T08:22:24+00:00 https://old.international-biopharma.com/seagens-cancer-drug-succeeds-in-must-win-trial/ 2023-09-25T08:40:24+00:00 https://old.international-biopharma.com/intarcias-diabetes-drug-device-combo-voted-down-again-by-fda-panel/ 2023-09-25T08:38:58+00:00 https://old.international-biopharma.com/genentech-takes-up-a-deal-to-make-molecular-glue-drugs/ 2023-09-25T08:36:50+00:00 https://old.international-biopharma.com/novartis-cancels-beigene-partnership-as-cancer-drug-gains-eu-approval/ 2023-09-25T08:35:43+00:00 https://old.international-biopharma.com/moderna-aims-for-the-stars-again-with-ambitious-drug-development-plan/ 2023-09-15T13:10:48+00:00 https://old.international-biopharma.com/after-ipo-success-acelyrin-hits-trial-setback-with-inflammation-drug/ 2023-09-15T13:07:12+00:00 https://old.international-biopharma.com/with-latest-fundraise-rome-therapeutics-works-to-drug-the-dark-genome/ 2023-09-15T12:45:53+00:00 https://old.international-biopharma.com/new-startup-arialys-takes-aim-at-the-immune-system-hoping-to-create-neuropsychiatry-drugs/ 2023-09-15T12:42:51+00:00 https://old.international-biopharma.com/rapid-evolution-of-the-biotech-industry-2023-and-beyond/ 2023-09-14T14:15:12+00:00 https://old.international-biopharma.com/a-summary-of-the-pharmaceutical-development-process-the-changes-and-challenges-and-future-opportunities/ 2023-09-14T14:12:55+00:00 https://old.international-biopharma.com/developing-robust-analytical-methods-for-early-stage-biologics/ 2023-09-14T14:10:33+00:00 https://old.international-biopharma.com/how-to-develop-a-successful-in-vitro-screening-strategy/ 2023-09-14T14:07:28+00:00 https://old.international-biopharma.com/accelerating-biologics-manufacturing-strategies-for-efficient-production-timelines/ 2023-09-14T14:05:14+00:00 https://old.international-biopharma.com/how-can-the-pharmaceutical-industry-overcome-barriers-to-reducing-its-carbon-footprint/ 2023-09-14T14:02:54+00:00 https://old.international-biopharma.com/innovative-laboratory-testing-methods-for-clinical-monitoring-of-cell-therapies-using-flow-cytometry-ddpcr-and-qpcr-assays/ 2023-09-14T13:59:42+00:00 https://old.international-biopharma.com/using-a-lims-to-improve-bottom-line-profitability/ 2023-09-14T13:37:12+00:00 https://old.international-biopharma.com/go-to-market-challenges-of-car-t-therapies-2/ 2023-09-14T13:32:31+00:00 https://old.international-biopharma.com/recreating-life-in-the-lab-how-predictive-human-organ-models-are-transforming-the-efficiency-of-drug-discovery/ 2023-09-14T13:32:12+00:00 https://old.international-biopharma.com/cell-therapy-challenges-and-perspectives-2/ 2023-09-14T13:31:54+00:00 https://old.international-biopharma.com/are-we-ready-to-formulate-the-next-generation-of-small-targeted-therapeutics/ 2023-09-14T13:31:38+00:00 https://old.international-biopharma.com/csos-in-cdmos-giving-mrna-manufacturing-considerations/ 2023-09-14T13:31:29+00:00 https://old.international-biopharma.com/utilising-size-selection-to-enhance-gene-synthesis-in-synthetic-biology-workflows/ 2023-09-14T13:31:20+00:00 https://old.international-biopharma.com/augmenting-inspiration-with-generative-chemistry/ 2023-09-14T13:31:10+00:00 https://old.international-biopharma.com/essential-considerations-for-a-successful-submission-under-eu-ctr/ 2023-09-14T13:30:32+00:00 https://old.international-biopharma.com/elrig-uk-establishes-engagement-strategy-work-group/ 2023-09-14T12:20:10+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/09/ELRIG-ESWG.png https://old.international-biopharma.com/seagen-partners-with-nurix-to-create-new-kind-of-cancer-drug/ 2023-09-11T08:30:45+00:00 https://old.international-biopharma.com/otsuka-taps-shape-in-deal-to-design-eye-gene-therapies/ 2023-09-11T08:28:44+00:00 https://old.international-biopharma.com/astrazeneca-seeking-new-drug-targets-taps-a-genomics-biotech-and-its-ai-technology/ 2023-09-11T08:26:15+00:00 https://old.international-biopharma.com/sygnature-discovery/ 2023-09-08T13:06:03+00:00 https://old.international-biopharma.com/polypure/ 2023-09-08T09:28:33+00:00 https://old.international-biopharma.com/expanded-range-of-real-time-liquid-flowmeters/ 2023-09-05T08:51:45+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/09/BiotechPR10-imageB.jpeg https://old.international-biopharma.com/wp-content/uploads/2023/09/BiotechPR10-imageA-scaled.jpg https://old.international-biopharma.com/bio-europe/ 2023-09-04T08:58:04+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-2-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-1-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-3-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/09/Bio-Europe-Pic-4-scaled.jpg https://old.international-biopharma.com/fda-documents-hint-at-uphill-battle-for-broad-approval-of-sages-depression-drug/ 2023-09-04T08:29:18+00:00 https://old.international-biopharma.com/roche-claims-study-success-for-targeted-drug-in-early-lung-cancer/ 2023-09-04T08:28:06+00:00 https://old.international-biopharma.com/sanofi-appoints-a-venture-investor-to-rd-head-as-executive-team-expands/ 2023-09-04T08:27:26+00:00 https://old.international-biopharma.com/sage-reeling-from-depression-drug-decision-to-lay-off-40-of-workforce/ 2023-09-04T08:26:39+00:00 https://old.international-biopharma.com/ddl-2023/ 2023-08-29T14:45:37+00:00 https://old.international-biopharma.com/astrazeneca-the-latest-pharma-to-challenge-drug-pricing-law/ 2023-08-28T08:55:22+00:00 https://old.international-biopharma.com/merck-kicks-off-phase-3-tests-for-pcsk9-cholesterol-pill/ 2023-08-28T08:53:57+00:00 https://old.international-biopharma.com/roches-surprise-study-results-spur-new-optimism-for-tigit-drugs/ 2023-08-28T08:53:05+00:00 https://old.international-biopharma.com/neumora-a-richly-funded-brain-drug-developer-readies-for-an-ipo/ 2023-08-28T08:51:51+00:00 https://old.international-biopharma.com/gilead-antibody-drug-shows-signs-of-potential-in-early-lung-cancer/ 2023-08-21T08:52:54+00:00 https://old.international-biopharma.com/merck-says-drug-acquired-in-1b-buyout-scores-in-large-kidney-cancer-study/ 2023-08-21T08:51:53+00:00 https://old.international-biopharma.com/moderna-builds-case-for-updated-covid-shot-ahead-of-latest-booster-push/ 2023-08-21T08:50:29+00:00 https://old.international-biopharma.com/fda-clears-ipsen-bone-drug-despite-questions-about-its-benefits/ 2023-08-21T08:49:39+00:00 https://old.international-biopharma.com/randox-laboratories/ 2023-08-17T14:10:56+00:00 https://old.international-biopharma.com/cphi-milan-returns-to-fiera-milano-and-the-lombardy-pharma-region-for-2024/ 2023-08-15T08:35:21+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/08/CPHI_5717336-2-fiera-milano-new1.jpeg https://old.international-biopharma.com/novo-hikes-sales-outlook-on-rising-potential-for-obesity-diabetes-drugs/ 2023-08-14T08:38:36+00:00 https://old.international-biopharma.com/family-of-henrietta-lacks-sues-ultragenyx-over-use-of-hela-cell-line/ 2023-08-14T08:37:50+00:00 https://old.international-biopharma.com/jj-grows-cancer-drug-portfolio-with-newly-approved-bispecific/ 2023-08-14T08:37:00+00:00 https://old.international-biopharma.com/novo-adds-another-obesity-drug-in-1b-deal-for-startup-inversago/ 2023-08-14T08:36:02+00:00 https://old.international-biopharma.com/elrig-are-delighted-to-be-able-to-offer-three-fantastic-awards-at-drug-discovery-2023/ 2023-07-13T14:13:45+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/07/AWARDS-2-square.png https://old.international-biopharma.com/wp-content/uploads/2023/07/Poster-award-photo.jpg https://old.international-biopharma.com/multiparticulates-a-flexible-approach-for-new-dosage-forms/ 2023-07-13T13:21:22+00:00 https://old.international-biopharma.com/the-one-that-gut-away-measuring-microbial-vocs-from-breath/ 2023-07-13T13:20:33+00:00 https://old.international-biopharma.com/beyond-symptom-relief-human-ipsc-derived-models-for-the-development-of-life-changing-therapies-for-neurodegenerative-diseases/ 2023-07-13T13:20:07+00:00 https://old.international-biopharma.com/analytical-method-release-and-stability-platform-for-rna-drug-substance/ 2023-07-13T13:19:39+00:00 https://old.international-biopharma.com/are-nitrosamines-a-concern-for-biologic-manufacturers/ 2023-07-13T13:18:46+00:00 https://old.international-biopharma.com/the-opportunities-and-obstacles-of-filling-and-packaging-pre-filled-syringes/ 2023-07-13T13:18:17+00:00 https://old.international-biopharma.com/the-future-of-the-connected-drug-delivery-device-market-key-areas-for-innovation/ 2023-07-13T13:17:47+00:00 https://old.international-biopharma.com/causal-inference-and-the-future-of-clinical-trials/ 2023-07-13T13:17:09+00:00 https://old.international-biopharma.com/generating-powerful-new-pharma-insights-from-graphs/ 2023-07-13T13:16:41+00:00 https://old.international-biopharma.com/high-accuracy-flow-meter-for-low-flow-measurements/ 2023-07-13T13:16:16+00:00 https://old.international-biopharma.com/global-sterile-manufacturing-and-lyophilization-capabilities-of-large-and-small-molecule-biologics-pci-shows-the-way/ 2023-07-13T13:15:50+00:00 https://old.international-biopharma.com/revvity-establishes-scientific-centre-of-excellence-for-genomic-insight-in-cambridge/ 2023-07-13T08:35:19+00:00 https://old.international-biopharma.com/are-nitrosamines-a-concern-for-biologic-manufacturers-2/ 2023-07-12T14:18:50+00:00 https://old.international-biopharma.com/autoscribe-informatics-matrix-gemini-lims/ 2023-07-12T13:07:43+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/07/Autoscribe-Labteam_withASLogo_700px.jpg https://old.international-biopharma.com/wp-content/uploads/2023/07/Autoscribe_New_Large_Icons_Matrix-Gemini_Apr23_600px.png https://old.international-biopharma.com/wp-content/uploads/2023/07/Autoscribe_Manufacturing_LIMS_Jun23_750px.png https://old.international-biopharma.com/fda-grants-eisais-leqembi-full-approval-opening-door-to-wider-use-of-alzheimers-drug/ 2023-07-10T08:29:11+00:00 https://old.international-biopharma.com/pfizer-backs-crispr-biotech-caribou-in-latest-cell-therapy-investment/ 2023-07-10T08:24:43+00:00 https://old.international-biopharma.com/with-fda-approval-in-hand-biomarin-lays-out-plan-to-sell-2-9m-gene-therapy/ 2023-07-10T08:19:51+00:00 https://old.international-biopharma.com/brii-buys-further-into-vbi-therapy-expanding-hepatitis-b-partnership/ 2023-07-10T08:14:04+00:00 https://old.international-biopharma.com/removing-bubble-trouble-from-micro-and-nanofluidic-systems/ 2023-07-07T13:26:34+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/07/BiotechPR7-imageA.jpg https://old.international-biopharma.com/inline-degasser-for-high-flow-rate-applications/ 2023-07-07T13:22:46+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/07/BiotechPR6-image.jpg https://old.international-biopharma.com/regulatory-compliant-flexible-plastic-tubing/ 2023-07-07T13:19:55+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/07/BiotechPR5-imageA-scaled.jpg https://old.international-biopharma.com/lilly-to-acquire-cancer-antibody-drug-startup-emergence/ 2023-07-03T08:27:42+00:00 https://old.international-biopharma.com/biomarin-finally-secures-fda-approval-of-hemophilia-gene-therapy/ 2023-07-03T08:26:17+00:00 https://old.international-biopharma.com/lilly-takes-over-partner-working-on-cell-therapies-for-diabetes/ 2023-07-03T08:25:19+00:00 https://old.international-biopharma.com/intercept-to-abandon-nash-research-lay-off-staff-after-fda-drug-rejection/ 2023-06-26T08:16:06+00:00 https://old.international-biopharma.com/sarepta-prices-duchenne-gene-therapy-at-3-2m/ 2023-06-26T08:14:25+00:00 https://old.international-biopharma.com/amylyxs-als-drug-gets-pushback-from-european-regulators/ 2023-06-26T08:10:55+00:00 https://old.international-biopharma.com/driving-successful-therapeutic-and-diagnostic-development-effective-practices-for-integrating-biomarkers-biospecimens-and-science-from-concept-through-clinic-to-cloud/ 2023-06-15T13:50:51+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/06/Concept-Cloud-Webinar_Slide-4-1200x300-Option-1.jpg https://old.international-biopharma.com/after-years-of-disappointment-cancer-vaccines-show-new-promise/ 2023-06-12T09:57:41+00:00 https://old.international-biopharma.com/astrazeneca-teams-up-with-startup-quell-joining-treg-cell-therapy-hunt/ 2023-06-12T09:53:42+00:00 https://old.international-biopharma.com/medicare-sets-next-tranche-of-drugs-to-face-price-hike-penalties/ 2023-06-12T09:49:48+00:00 https://old.international-biopharma.com/fda-panel-backs-full-approval-for-eisai-biogen-alzheimers-drug/ 2023-06-12T09:45:25+00:00 https://old.international-biopharma.com/synergy/ 2023-06-06T09:41:36+00:00 https://old.international-biopharma.com/coherus-sets-steep-discount-for-humira-copycat-plans-direct-sales/ 2023-06-05T08:51:27+00:00 https://old.international-biopharma.com/novartis-drug-helps-stop-breast-cancers-return-in-large-study/ 2023-06-05T08:47:03+00:00 https://old.international-biopharma.com/fda-clears-narrow-use-of-lynparza-in-early-prostate-cancer-continuing-shift-on-parp-drugs/ 2023-06-05T08:45:17+00:00 https://old.international-biopharma.com/sanofi-drug-acquired-from-a-startup-shows-early-potential-in-ms/ 2023-06-05T08:39:08+00:00 https://old.international-biopharma.com/medicare-keeps-limits-on-alzheimers-drug-coverage-but-loosens-policy/ 2023-06-05T08:35:35+00:00 https://old.international-biopharma.com/moderna-reports-encouraging-early-data-for-one-of-its-rare-disease-medicines/ 2023-05-22T08:34:10+00:00 https://old.international-biopharma.com/teva-puts-rival-to-prometheus-pfizer-drugs-at-center-of-turnaround-plans/ 2023-05-22T08:33:08+00:00 https://old.international-biopharma.com/supreme-court-sides-with-sanofi-regeneron-in-patent-fight-with-amgen/ 2023-05-22T08:31:38+00:00 https://old.international-biopharma.com/future-of-intercepts-nash-drug-in-doubt-after-fda-panel-rejection/ 2023-05-22T08:30:44+00:00 https://old.international-biopharma.com/sgs-pace-is-a-seamless-combination-of-world-leading-development-bioanalysis-and-clinical-research-through-one-point-of-contact/ 2023-05-16T10:46:50+00:00 https://old.international-biopharma.com/fda-panel-narrowly-backs-approval-of-sareptas-duchenne-gene-therapy/ 2023-05-15T08:11:04+00:00 https://old.international-biopharma.com/amylyxs-als-drug-again-surpasses-wall-street-expectations/ 2023-05-15T08:07:57+00:00 https://old.international-biopharma.com/cancer-vaccine-from-biontech-roche-shows-potential-in-small-study/ 2023-05-15T08:05:03+00:00 https://old.international-biopharma.com/gilead-acquires-san-diego-startup-for-early-stage-cancer-immune-drugs/ 2023-05-15T07:59:48+00:00 https://old.international-biopharma.com/elrig-uk-appoints-nick-clare-to-board-as-vendor-strategy-work-group-lead/ 2023-05-11T11:06:14+00:00 https://old.international-biopharma.com/15th-annual-pegs-europe-protein-antibody-engineering-summit/ 2023-05-10T15:13:24+00:00 https://old.international-biopharma.com/aldevron/ 2023-05-10T14:27:55+00:00 https://old.international-biopharma.com/world-vaccine-congress-europe-2023/ 2023-04-26T14:36:48+00:00 https://old.international-biopharma.com/pci-pharma-services-announces-new-sterile-fill-finish-capabilities-now-available-in-melbourne-and-san-diego/ 2023-04-24T09:04:19+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/04/PCI_Microcell-1.jpg https://old.international-biopharma.com/jj-study-data-show-dramatic-benefit-to-multiple-myeloma-cell-therapy/ 2023-04-24T08:40:28+00:00 https://old.international-biopharma.com/biotech-layoffs-gather-pace-as-industry-downturn-persists-2/ 2023-04-24T08:39:24+00:00 https://old.international-biopharma.com/apellis-immune-system-drug-hits-a-setback-in-als/ 2023-04-24T08:37:13+00:00 https://old.international-biopharma.com/sensitive-hplc-refractive-index-detector/ 2023-04-24T08:34:16+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/04/BiotechPR3-imageA.jpg https://old.international-biopharma.com/moderna-merck-data-support-claim-of-cancer-vaccines-promise/ 2023-04-17T08:23:03+00:00 https://old.international-biopharma.com/biotech-layoffs-gather-pace-as-industry-downturn-persists/ 2023-04-17T08:21:45+00:00 https://old.international-biopharma.com/manufacturing-issues-spur-fda-to-deny-approval-of-lilly-colitis-drug/ 2023-04-17T08:20:30+00:00 https://old.international-biopharma.com/merck-to-buy-inflammatory-disease-drugmaker-prometheus-for-10-8b/ 2023-04-17T08:19:44+00:00 https://old.international-biopharma.com/compact-modular-detectors-for-biomolecular-applications/ 2023-04-17T08:12:25+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/04/BiotechPR2-imageA.jpg https://old.international-biopharma.com/wp-content/uploads/2023/04/Picture-1.png https://old.international-biopharma.com/sonotec-presents-extended-non-contact-flow-meter-series-at-interphex/ 2023-04-11T15:03:02+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/04/sonoflow-co.55-0250-v3.0-sonotec-2-1-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/04/sonoflow-co.55-v3.0-portfolio-sonotec-2-scaled.jpg https://old.international-biopharma.com/advancing-drug-discovery-by-connecting-the-community/ 2023-04-05T14:30:45+00:00 https://old.international-biopharma.com/technological-advancements-support-rna-and-oligonucleotide-sequence-confirmation/ 2023-04-05T14:30:18+00:00 https://old.international-biopharma.com/strategies-for-simplifying-biopharmas-digital-journey/ 2023-04-05T14:29:42+00:00 https://old.international-biopharma.com/looking-beyond-plasmids-whats-on-the-horizon-for-gene-therapy-manufacture/ 2023-04-05T14:29:20+00:00 https://old.international-biopharma.com/how-do-you-build-an-aav-manufacturing-platform/ 2023-04-05T14:28:52+00:00 https://old.international-biopharma.com/how-do-we-address-product-finishing-and-dispensing-challenges-for-future-pandemics/ 2023-04-05T14:28:24+00:00 https://old.international-biopharma.com/trends-paving-the-way-for-an-influx-of-biosimilar-development/ 2023-04-05T14:27:54+00:00 https://old.international-biopharma.com/slps-use-in-the-pharmaceutical-world/ 2023-04-05T14:27:22+00:00 https://old.international-biopharma.com/integrated-laboratory-informatics-are-organisations-really-exploiting-the-benefits/ 2023-04-05T14:26:57+00:00 https://old.international-biopharma.com/ensuring-success-in-pharmacovigilance-and-patient-safety/ 2023-04-05T14:26:32+00:00 https://old.international-biopharma.com/preparing-for-success-how-to-have-a-positive-fda-inspection/ 2023-04-05T14:26:08+00:00 https://old.international-biopharma.com/managing-the-transition-to-next-generation-sequencing/ 2023-04-05T14:25:42+00:00 https://old.international-biopharma.com/bluebird-awaiting-fda-feedback-says-its-likely-to-miss-filing-goal-for-sickle-cell-gene-therapy/ 2023-04-03T08:36:15+00:00 https://old.international-biopharma.com/pharma-partner-sartorius-eyes-gene-therapy-market-with-2-6b-deal/ 2023-04-03T08:35:15+00:00 https://old.international-biopharma.com/gene-therapy-startup-vedere-to-close-two-years-after-launch/ 2023-04-03T08:33:48+00:00 https://old.international-biopharma.com/optimized-degassers-for-gpc-applications/ 2023-04-03T08:30:54+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/04/BiotechPR1-imageB.png https://old.international-biopharma.com/wp-content/uploads/2023/04/BiotechPR1-imageA.jpg https://old.international-biopharma.com/iktos-announces-closing-of-e15-5m-in-series-a-round/ 2023-04-03T08:19:45+00:00 https://old.international-biopharma.com/life-science-group-ltd-lsg/ 2023-03-28T10:06:55+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/03/LSG.jpg https://old.international-biopharma.com/wp-content/uploads/2023/03/LSG_1.jpg https://old.international-biopharma.com/wp-content/uploads/2023/03/LSG_2.jpg https://old.international-biopharma.com/stuart-peltz-founder-of-ptc-retires-after-25-years-as-ceo/ 2023-03-27T08:39:03+00:00 https://old.international-biopharma.com/sanofi-regeneron-surge-as-dupixent-scores-in-copd-trial/ 2023-03-27T08:37:10+00:00 https://old.international-biopharma.com/former-seagen-ceo-siegall-returns-to-biotech-as-head-of-early-stage-startup/ 2023-03-27T08:36:17+00:00 https://old.international-biopharma.com/biotech-startups-face-series-a-cliff-as-venture-capital-stays-cautious/ 2023-03-27T08:34:31+00:00 https://old.international-biopharma.com/biopharma-groups-cryopreservation-storage-equipment-solutions/ 2023-03-23T10:59:17+00:00 https://old.international-biopharma.com/fda-reversal-sets-up-high-stakes-hearing-on-sarepta-gene-therapy/ 2023-03-20T09:34:06+00:00 https://old.international-biopharma.com/merck-tigit-drug-misses-goal-in-lung-cancer-trial-adding-to-doubts-over-approach/ 2023-03-20T09:33:15+00:00 https://old.international-biopharma.com/in-pfizer-seagen-review-ftc-has-chance-to-set-new-pharma-precedent/ 2023-03-20T09:32:15+00:00 https://old.international-biopharma.com/takeda-chasing-bristol-myers-unveils-awaited-tyk2-drug-data/ 2023-03-20T09:31:12+00:00 https://old.international-biopharma.com/sanofi-joins-other-diabetes-drugmakers-in-cutting-insulin-prices/ 2023-03-20T09:27:06+00:00 https://old.international-biopharma.com/a-roche-arthritis-drug-fails-in-covid-19-casting-doubt-on-a-strained-hypothesis/ 2023-03-15T16:26:16+00:00 https://old.international-biopharma.com/oxford-genetics-signs-licensing-agreement-with-aldevron-to-market-lentiviral-packaging-plasmids/ 2023-03-15T16:22:08+00:00 https://old.international-biopharma.com/pci-pharma-services-expands-biologics-leadership-with-new-center-of-excellence-facility-in-the-midwest/ 2023-03-14T15:07:16+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/03/PCI-ResourceCardBG-TECH-Red-AutoInjector-v2-2.jpg https://old.international-biopharma.com/flow-robotics/ 2023-03-13T13:46:34+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/03/flowbot-newsl1.jpg https://old.international-biopharma.com/wp-content/uploads/2023/03/Flow-robotics-image.jpg https://old.international-biopharma.com/wp-content/uploads/2023/03/Flow-robotics-image_1.jpg https://old.international-biopharma.com/fda-finds-at-least-19-cases-of-skin-cancer-in-breast-implant-data-including-3-deaths/ 2023-03-13T09:59:35+00:00 https://old.international-biopharma.com/doj-charges-former-stimwave-ceo-with-fraud-scheme-that-added-a-fake-receiver-to-neurostim-device/ 2023-03-13T09:55:08+00:00 https://old.international-biopharma.com/after-slimming-down-applied-molecular-transport-no-closer-to-taking-uc-drug-into-phase-3/ 2023-03-13T09:51:00+00:00 https://old.international-biopharma.com/fdas-first-safer-technologies-nod-goes-to-endolumiks-glowing-tube-to-guide-weight-loss-surgeries/ 2023-03-13T09:49:16+00:00 https://old.international-biopharma.com/a-magic-whistle-hands-free-version-of-copd-breath-tech-improves-airflow-study-finds/ 2023-03-13T09:44:32+00:00 https://old.international-biopharma.com/sonotec-2/ 2023-03-07T16:19:01+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/02/sonoflow-co.55-v2.0-v3.0-portfolio-sonotec-2-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/02/sonocheck-abd06-portfolio-sonotec-2-scaled.jpg https://old.international-biopharma.com/valproic-acid-an-old-seizure-drug-sees-new-potential-in-preserving-donor-hearts/ 2023-03-06T15:06:06+00:00 https://old.international-biopharma.com/strategies-to-reduce-cold-chain-burden-in-biopharmaceuticals/ 2023-03-06T14:56:50+00:00 https://old.international-biopharma.com/bd-issues-cybersecurity-alert-for-hacking-risk-found-in-alaris-infusion-pump-software/ 2023-03-06T12:35:27+00:00 https://old.international-biopharma.com/fda-clears-galaxy-robotic-surgery-system-sending-lung-cancer-diagnosis-to-a-new-frontier/ 2023-03-06T10:26:08+00:00 https://old.international-biopharma.com/czi-in-chi-chan-zuckerberg-initiative-sets-first-location-for-1b-biohub-expansion/ 2023-03-06T10:15:41+00:00 https://old.international-biopharma.com/verus-eua-ambitions-crash-after-fda-declines-to-authorize-its-covid-treatment/ 2023-03-06T10:13:48+00:00 https://old.international-biopharma.com/viz-ai-secures-bristol-myers-squibbs-backing-for-hypertrophic-cardiomyopathy-spotting-ai/ 2023-03-06T10:12:55+00:00 https://old.international-biopharma.com/insulet-omnipods-higher-than-expected-demand-helps-set-new-revenue-record/ 2023-02-27T10:00:31+00:00 https://old.international-biopharma.com/olympus-mounts-370m-bid-to-acquire-gi-stent-maker-taewoong-medical/ 2023-02-27T09:47:22+00:00 https://old.international-biopharma.com/3d-printed-hearts-made-from-real-patient-data-could-pump-up-accuracy-of-tavr-implants/ 2023-02-27T09:43:55+00:00 https://old.international-biopharma.com/medtronic-pads-the-case-for-minimed-closed-loop-system-with-one-year-data-study-of-automated-meal-detection-app/ 2023-02-27T09:38:47+00:00 https://old.international-biopharma.com/destiny-seals-c-diff-therapys-phase-3-fate-with-sebela/ 2023-02-27T09:33:50+00:00 https://old.international-biopharma.com/catalyst-clinical-research/ 2023-02-20T13:43:07+00:00 https://old.international-biopharma.com/moderna-checks-a-few-boxes-in-phase-3-mrna-flu-shot-trial-but-misses-on-b-strains-and-safety/ 2023-02-20T09:27:33+00:00 https://old.international-biopharma.com/pfizer-pulls-50-of-people-from-phase-3-lyme-disease-study-for-gcp-violations-at-us-trial-sites/ 2023-02-20T09:24:29+00:00 https://old.international-biopharma.com/scientists-use-drug-to-lengthen-limb-bones-of-mice-with-rare-bone-disorder-potentially-avoiding-surgery/ 2023-02-20T09:23:07+00:00 https://old.international-biopharma.com/medtronic-fined-106m-in-trial-over-tavr-device-patent-infringement/ 2023-02-13T09:21:29+00:00 https://old.international-biopharma.com/nuvasive-globus-medical-ink-3-1b-orthopedic-device-merger-sending-investors-scrambling/ 2023-02-13T09:15:44+00:00 https://old.international-biopharma.com/blueprint-told-to-stop-sketching-as-fda-slaps-partial-hold-on-phase-1-2-trial/ 2023-02-13T09:13:24+00:00 https://old.international-biopharma.com/titan-medical-lays-off-70-of-staff-as-search-for-buyer-comes-up-short/ 2023-02-13T09:08:34+00:00 https://old.international-biopharma.com/gerresheimer-and-corning-announce-joint-venture-to-meet-growing-demand-for-velocity-vials-accelerating-the-delivery-of-lifesaving-treatments/ 2023-02-08T09:51:48+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/02/Gerresheimer.png https://old.international-biopharma.com/neither-ear-nor-there-altamira-stakes-for-sale-sign-again-after-asset-deal-crumbles-2/ 2023-02-06T10:01:44+00:00 https://old.international-biopharma.com/as-resmed-tops-1b-revenues-in-q2-ceo-says-philips-return-to-the-cpap-market-is-not-a-big-perturbation-to-long-term-strategy-2/ 2023-02-06T10:00:17+00:00 https://old.international-biopharma.com/goldfinch-bio-falls-from-the-sky-after-failing-to-find-a-path-forward-for-kidney-treatments-2/ 2023-02-06T09:58:48+00:00 https://old.international-biopharma.com/as-resmed-tops-1b-revenues-in-q2-ceo-says-philips-return-to-the-cpap-market-is-not-a-big-perturbation-to-long-term-strategy/ 2023-01-30T09:26:17+00:00 https://old.international-biopharma.com/neither-ear-nor-there-altamira-stakes-for-sale-sign-again-after-asset-deal-crumbles/ 2023-01-30T09:22:33+00:00 https://old.international-biopharma.com/researchers-predict-alzheimers-progression-3-5-years-early-with-unique-blood-test/ 2023-01-30T09:21:20+00:00 https://old.international-biopharma.com/goldfinch-bio-falls-from-the-sky-after-failing-to-find-a-path-forward-for-kidney-treatments/ 2023-01-30T09:19:19+00:00 https://old.international-biopharma.com/brand-new-state-of-the-art-nemera-manufacturing-facility-inaugurated-in-poland/ 2023-01-25T16:43:16+00:00 https://old.international-biopharma.com/wp-content/uploads/2023/01/1.-Nemera-ribbon-cutting-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/01/2.-Nemera-outdoor-picture-scaled.jpg https://old.international-biopharma.com/wp-content/uploads/2023/01/3.-Nemera-indoor-picture-scaled.jpg https://old.international-biopharma.com/why-wall-street-shrugged-at-lillys-alzheimers-setback/ 2023-01-23T09:28:21+00:00 https://old.international-biopharma.com/fda-rejects-lilly-alzheimers-drug-citing-insufficient-data/ 2023-01-23T09:27:35+00:00 https://old.international-biopharma.com/sun-pharma-to-buy-concert-pick-up-experimental-hair-loss-drug/ 2023-01-23T09:26:14+00:00 https://old.international-biopharma.com/beigene-wins-expanded-approval-for-leukemia-drug-intensifying-battle-with-abbvie-astrazeneca/ 2023-01-23T09:24:54+00:00 https://old.international-biopharma.com/fda-lifts-hold-on-astellas-gene-therapy-for-pompe-disease/ 2023-01-23T09:20:29+00:00 https://old.international-biopharma.com/bristol-myers-bayer-forecast-blockbuster-future-for-rival-blood-thinners/ 2023-01-16T09:42:04+00:00 https://old.international-biopharma.com/looking-past-humira-abbvie-boosts-sales-forecasts-for-successor-drugs/ 2023-01-16T09:39:48+00:00 https://old.international-biopharma.com/novo-nordisk-diabetes-pill-wins-fda-approval-for-first-line-use/ 2023-01-16T09:38:43+00:00 https://old.international-biopharma.com/sanofi-tops-off-venture-arm-bringing-fund-to-750m/ 2023-01-16T09:36:39+00:00 https://old.international-biopharma.com/festival-of-biologics-usa-san-diego/ 2023-01-12T10:05:41+00:00 https://old.international-biopharma.com/fda-approves-alzheimers-drug-from-eisai-biogen-in-closely-watched-decision/ 2023-01-09T10:05:56+00:00